Evidence map›Paper›PMID 25184293›Full record

ArticlePloS one2014

A CACNA1C variant associated with reduced voltage-dependent inactivation, increased CaV1.2 channel window current, and arrhythmogenesis.

Jessica A Hennessey, Nicole J Boczek, Yong-Hui Jiang, Joelle D Miller, William Patrick, Ryan Pfeiffer, Brittan S Sutphin, David J Tester, Hector Barajas-Martinez, Michael J Ackerman and 3 more

Open access · goldAbstract readClinical Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Geno- and phenotypic characteristics and clinical outcomes ofFrontiers in cardiovascular medicine · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Disruption of mitochondrial and lysosomal functions by humanFrontiers in molecular neuroscience · 2023
    Article
  9. CACNA1C-Related Channelopathies.Handbook of experimental pharmacology · 2023
    Review
  10. Increased CaScientific reports · 2022
    Article
  11. Article
  12. Voltage-Gated CaFrontiers in synaptic neuroscience · 2021
    Review
  13. Review
  14. Review
  15. Dysfunctional Cav1.2 channel in Timothy syndrome, from cell to bedside.Experimental biology and medicine (Maywood, N.J.) · 2019
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Role of CACNA1C gene polymorphisms and protein expressions in the pathogenesis of schizophrenia: a case-control study in a Chinese population.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jessica A HennesseyDepartment of Medicine/Cardiology, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, United States of America.
Nicole J BoczekDepartments of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America.
Yong-Hui JiangDepartment of Neurobiology, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, United States of America.
Joelle D MillerDepartment of Pediatrics, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, United States of America.
William PatrickDepartment of Medicine/Cardiology, Duke University School of Medicine, Durham, North Carolina, United States of America.
Ryan PfeifferMasonic Medical Research Laboratory, Utica, New York, United States of America.
Brittan S SutphinDepartments of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America.
David J TesterDepartments of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America.
Hector Barajas-MartinezMasonic Medical Research Laboratory, Utica, New York, United States of America.
Michael J AckermanDepartments of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America; Departments of Internal Medicine and Pediatrics & Adolescent Medicine/Divisions of Cardiovascular Diseases and Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota, United States of America.
Charles AntzelevitchMasonic Medical Research Laboratory, Utica, New York, United States of America.
Ronald KanterDepartment of Pediatrics, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Pediatrics/Cardiology, Duke University School of Medicine, Durham, North Carolina, United States of America.
Geoffrey S PittDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Neurobiology, Duke University School of Medicine, Durham, North Carolina, United States of America.
Duke University · USMayo Clinic · USMasonic Medical Research Laboratory · USVirginia Tech · US

Funding

Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)R01HD042569 · NICHD · MAYO CLINIC ROCHESTER · PI ACKERMAN, MICHAEL JOHN · 2002 to 2017
$6.9M
ELECTRICAL HETEROGENEITY AND CARDIAC ARRHYTHMIASR01HL047678 · NHLBI · MASONIC MEDICAL RESEARCH LABORATORY, INC · PI ANTZELEVITCH, CHARLES · 1993 to 2014
$5.7M
Calcium regulation and dysregulation of cardiac ion channelsR01HL071165 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI PITT, GEOFFREY S · 2002 to 2017
$5.2M
Structural studies of NaV1.5 and functional implications.R01HL112918 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI PITT, GEOFFREY S · 2013 to 2016
$1.5M
Fibroblast Growth Factor Homologous Factors: Modulation of L-type Calcium ChannelF30HL112540 · NHLBI · DUKE UNIVERSITY · PI HENNESSEY, JESSICA AMENTA · 2012 to 2013
$84k
NHLBI NIH HHS F30 HL112540NHLBI NIH HHS R01 HL047678NHLBI NIH HHS R01 HL071165NHLBI NIH HHS R01 HL112918NHLBI NIH HHS R01 HL47678NHLBI NIH HHS R01 HL71165NICHD NIH HHS R01 HD042569NICHD NIH HHS R01 HD42569
6 · The paper itself

Abstract

Mutations in CACNA1C that increase current through the CaV1.2 L-type Ca2+ channel underlie rare forms of long QT syndrome (LQTS), and Timothy syndrome (TS). We identified a variant in CACNA1C in a male child of Filipino descent with arrhythmias and extracardiac features by candidate gene sequencing and performed functional expression studies to electrophysiologically characterize the effects of the variant on CaV1.2 channels. As a baby, the subject developed seizures and displayed developmental delays at 30 months of age. At age 5 years, he displayed a QTc of 520 ms and experienced recurrent VT. Physical exam at 17 years of age was notable for microcephaly, short stature, lower extremity weakness and atrophy with hyperreflexia, spastic diplegia, multiple dental caries and episodes of rhabdomyolysis. Candidate gene sequencing identified a G>C transversion at position 5731 of CACNA1C (rs374528680) predicting a glycine>arginine substitution at residue 1911 (p.G1911R) of CaV1.2. The allele frequency of this variant is 0.01 in Malays, but absent in 984 Caucasian alleles and in the 1000 genomes project. In electrophysiological analyses, the variant decreased voltage-dependent inactivation, thus causing a gain of function of CaV1.2. We also observed a negative shift of V1/2 of activation and positive shift of V1/2 of channel inactivation, resulting in an increase of the window current. Together, these suggest a gain-of-function effect on CaV1.2 and suggest increased susceptibility for arrhythmias in certain clinical settings. The p.G1911R variant was also identified in a case of sudden unexplained infant death (SUID), for which an increasing number of clinical observations have demonstrated can be associated with arrhythmogenic mutations in cardiac ion channels. In summary, the combined effects of the CACNA1C variant to diminish voltage-dependent inactivation of CaV1.2 and increase window current expand our appreciation of mechanisms by which a gain of function of CaV1.2 can contribute to QT prolongation.

Indexed as

Autistic DisorderCalcium Channels, L-TypeLong QT SyndromeMutationSyndactylyChild, PreschoolFemaleHumansInfantMaleMembrane PotentialsCACNA1C protein, humanCalcium Channels, L-TypeL-type calcium channel alpha(1C)

Identifiers

PMID25184293
PMCPMC4153713
OpenAlexW2029750615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.